nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—HTR6—Raloxifene—osteoporosis	0.145	0.225	CbGbCtD
Nortriptyline—ALB—Estropipate—osteoporosis	0.0767	0.119	CbGbCtD
Nortriptyline—CYP1A2—Estropipate—osteoporosis	0.0459	0.0713	CbGbCtD
Nortriptyline—CYP2C9—Estropipate—osteoporosis	0.0414	0.0642	CbGbCtD
Nortriptyline—ALB—Estradiol—osteoporosis	0.0319	0.0495	CbGbCtD
Nortriptyline—CYP2C19—Cholecalciferol—osteoporosis	0.0256	0.0398	CbGbCtD
Nortriptyline—CYP3A5—Estradiol—osteoporosis	0.0256	0.0398	CbGbCtD
Nortriptyline—CYP3A4—Estropipate—osteoporosis	0.0241	0.0374	CbGbCtD
Nortriptyline—CYP3A4—Calcitriol—osteoporosis	0.0241	0.0374	CbGbCtD
Nortriptyline—CYP1A2—Conjugated Estrogens—osteoporosis	0.0217	0.0337	CbGbCtD
Nortriptyline—CYP2C9—Cholecalciferol—osteoporosis	0.0213	0.0331	CbGbCtD
Nortriptyline—CYP2C19—Estradiol—osteoporosis	0.0207	0.0321	CbGbCtD
Nortriptyline—CYP2D6—Cholecalciferol—osteoporosis	0.0195	0.0303	CbGbCtD
Nortriptyline—CYP3A4—Ergocalciferol—osteoporosis	0.0192	0.0299	CbGbCtD
Nortriptyline—CYP1A2—Estradiol—osteoporosis	0.0191	0.0296	CbGbCtD
Nortriptyline—CYP2C9—Estradiol—osteoporosis	0.0172	0.0267	CbGbCtD
Nortriptyline—CYP3A4—Raloxifene—osteoporosis	0.016	0.0249	CbGbCtD
Nortriptyline—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0155	0.0241	CbGbCtD
Nortriptyline—CYP3A4—Cholecalciferol—osteoporosis	0.0124	0.0192	CbGbCtD
Nortriptyline—CYP3A4—Conjugated Estrogens—osteoporosis	0.0114	0.0177	CbGbCtD
Nortriptyline—CYP3A4—Estradiol—osteoporosis	0.00999	0.0155	CbGbCtD
Nortriptyline—Feeling abnormal—Ibandronate—osteoporosis	0.000374	0.00145	CcSEcCtD
Nortriptyline—Tremor—Zoledronate—osteoporosis	0.000373	0.00145	CcSEcCtD
Nortriptyline—Nervousness—Conjugated Estrogens—osteoporosis	0.000372	0.00144	CcSEcCtD
Nortriptyline—Urticaria—Alendronate—osteoporosis	0.00037	0.00144	CcSEcCtD
Nortriptyline—Anxiety—Pamidronate—osteoporosis	0.00037	0.00143	CcSEcCtD
Nortriptyline—Ill-defined disorder—Zoledronate—osteoporosis	0.000369	0.00143	CcSEcCtD
Nortriptyline—Abdominal pain—Alendronate—osteoporosis	0.000369	0.00143	CcSEcCtD
Nortriptyline—Body temperature increased—Alendronate—osteoporosis	0.000369	0.00143	CcSEcCtD
Nortriptyline—Shock—Risedronate—osteoporosis	0.000368	0.00143	CcSEcCtD
Nortriptyline—Discomfort—Pamidronate—osteoporosis	0.000367	0.00142	CcSEcCtD
Nortriptyline—Agitation—Zoledronate—osteoporosis	0.000366	0.00142	CcSEcCtD
Nortriptyline—Body temperature increased—Raloxifene—osteoporosis	0.000363	0.00141	CcSEcCtD
Nortriptyline—Abdominal pain—Raloxifene—osteoporosis	0.000363	0.00141	CcSEcCtD
Nortriptyline—Vision blurred—Conjugated Estrogens—osteoporosis	0.000361	0.0014	CcSEcCtD
Nortriptyline—Urticaria—Ibandronate—osteoporosis	0.000361	0.0014	CcSEcCtD
Nortriptyline—Malaise—Zoledronate—osteoporosis	0.000359	0.00139	CcSEcCtD
Nortriptyline—Abdominal pain—Ibandronate—osteoporosis	0.000359	0.00139	CcSEcCtD
Nortriptyline—Body temperature increased—Ibandronate—osteoporosis	0.000359	0.00139	CcSEcCtD
Nortriptyline—Confusional state—Pamidronate—osteoporosis	0.000359	0.00139	CcSEcCtD
Nortriptyline—Syncope—Zoledronate—osteoporosis	0.000357	0.00138	CcSEcCtD
Nortriptyline—Leukopenia—Zoledronate—osteoporosis	0.000356	0.00138	CcSEcCtD
Nortriptyline—Oedema—Pamidronate—osteoporosis	0.000356	0.00138	CcSEcCtD
Nortriptyline—Urticaria—Calcitriol—osteoporosis	0.000353	0.00137	CcSEcCtD
Nortriptyline—Hepatitis—Estradiol—osteoporosis	0.000352	0.00137	CcSEcCtD
Nortriptyline—Palpitations—Zoledronate—osteoporosis	0.000352	0.00136	CcSEcCtD
Nortriptyline—Body temperature increased—Calcitriol—osteoporosis	0.000351	0.00136	CcSEcCtD
Nortriptyline—Abdominal pain—Calcitriol—osteoporosis	0.000351	0.00136	CcSEcCtD
Nortriptyline—Hypoaesthesia—Estradiol—osteoporosis	0.000351	0.00136	CcSEcCtD
Nortriptyline—Shock—Pamidronate—osteoporosis	0.00035	0.00136	CcSEcCtD
Nortriptyline—Loss of consciousness—Zoledronate—osteoporosis	0.00035	0.00136	CcSEcCtD
Nortriptyline—Hypersensitivity—Estropipate—osteoporosis	0.000349	0.00135	CcSEcCtD
Nortriptyline—Thrombocytopenia—Pamidronate—osteoporosis	0.000348	0.00135	CcSEcCtD
Nortriptyline—Vomiting—Etidronic acid—osteoporosis	0.000348	0.00135	CcSEcCtD
Nortriptyline—Oedema peripheral—Estradiol—osteoporosis	0.000347	0.00135	CcSEcCtD
Nortriptyline—Tachycardia—Pamidronate—osteoporosis	0.000347	0.00135	CcSEcCtD
Nortriptyline—Rash—Etidronic acid—osteoporosis	0.000345	0.00134	CcSEcCtD
Nortriptyline—Convulsion—Zoledronate—osteoporosis	0.000345	0.00134	CcSEcCtD
Nortriptyline—Dermatitis—Etidronic acid—osteoporosis	0.000345	0.00134	CcSEcCtD
Nortriptyline—Hyperhidrosis—Pamidronate—osteoporosis	0.000344	0.00133	CcSEcCtD
Nortriptyline—Syncope—Conjugated Estrogens—osteoporosis	0.000344	0.00133	CcSEcCtD
Nortriptyline—Hypertension—Zoledronate—osteoporosis	0.000344	0.00133	CcSEcCtD
Nortriptyline—Hypersensitivity—Alendronate—osteoporosis	0.000344	0.00133	CcSEcCtD
Nortriptyline—Headache—Etidronic acid—osteoporosis	0.000343	0.00133	CcSEcCtD
Nortriptyline—Asthenia—Estropipate—osteoporosis	0.00034	0.00132	CcSEcCtD
Nortriptyline—Anorexia—Pamidronate—osteoporosis	0.000339	0.00131	CcSEcCtD
Nortriptyline—Palpitations—Conjugated Estrogens—osteoporosis	0.000339	0.00131	CcSEcCtD
Nortriptyline—Insomnia—Risedronate—osteoporosis	0.000338	0.00131	CcSEcCtD
Nortriptyline—Anxiety—Zoledronate—osteoporosis	0.000338	0.00131	CcSEcCtD
Nortriptyline—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000337	0.00131	CcSEcCtD
Nortriptyline—Paraesthesia—Risedronate—osteoporosis	0.000336	0.0013	CcSEcCtD
Nortriptyline—Pruritus—Estropipate—osteoporosis	0.000335	0.0013	CcSEcCtD
Nortriptyline—Discomfort—Zoledronate—osteoporosis	0.000335	0.0013	CcSEcCtD
Nortriptyline—Asthenia—Alendronate—osteoporosis	0.000335	0.0013	CcSEcCtD
Nortriptyline—Hypersensitivity—Ibandronate—osteoporosis	0.000335	0.0013	CcSEcCtD
Nortriptyline—Hypotension—Pamidronate—osteoporosis	0.000332	0.00129	CcSEcCtD
Nortriptyline—Convulsion—Conjugated Estrogens—osteoporosis	0.000332	0.00129	CcSEcCtD
Nortriptyline—Dry mouth—Zoledronate—osteoporosis	0.000331	0.00129	CcSEcCtD
Nortriptyline—Fatigue—Ethinyl Estradiol—osteoporosis	0.000331	0.00128	CcSEcCtD
Nortriptyline—Pruritus—Alendronate—osteoporosis	0.00033	0.00128	CcSEcCtD
Nortriptyline—Dyspepsia—Risedronate—osteoporosis	0.000329	0.00128	CcSEcCtD
Nortriptyline—Eye disorder—Estradiol—osteoporosis	0.000329	0.00128	CcSEcCtD
Nortriptyline—Tinnitus—Estradiol—osteoporosis	0.000329	0.00127	CcSEcCtD
Nortriptyline—Constipation—Ethinyl Estradiol—osteoporosis	0.000328	0.00127	CcSEcCtD
Nortriptyline—Confusional state—Zoledronate—osteoporosis	0.000328	0.00127	CcSEcCtD
Nortriptyline—Hypersensitivity—Calcitriol—osteoporosis	0.000327	0.00127	CcSEcCtD
Nortriptyline—Flushing—Estradiol—osteoporosis	0.000327	0.00127	CcSEcCtD
Nortriptyline—Asthenia—Ibandronate—osteoporosis	0.000326	0.00126	CcSEcCtD
Nortriptyline—Anxiety—Conjugated Estrogens—osteoporosis	0.000325	0.00126	CcSEcCtD
Nortriptyline—Nausea—Etidronic acid—osteoporosis	0.000325	0.00126	CcSEcCtD
Nortriptyline—Oedema—Zoledronate—osteoporosis	0.000325	0.00126	CcSEcCtD
Nortriptyline—Diarrhoea—Estropipate—osteoporosis	0.000324	0.00126	CcSEcCtD
Nortriptyline—Fatigue—Risedronate—osteoporosis	0.000323	0.00125	CcSEcCtD
Nortriptyline—Insomnia—Pamidronate—osteoporosis	0.000322	0.00125	CcSEcCtD
Nortriptyline—Pruritus—Ibandronate—osteoporosis	0.000321	0.00125	CcSEcCtD
Nortriptyline—Constipation—Risedronate—osteoporosis	0.00032	0.00124	CcSEcCtD
Nortriptyline—Shock—Zoledronate—osteoporosis	0.00032	0.00124	CcSEcCtD
Nortriptyline—Paraesthesia—Pamidronate—osteoporosis	0.000319	0.00124	CcSEcCtD
Nortriptyline—Diarrhoea—Alendronate—osteoporosis	0.000319	0.00124	CcSEcCtD
Nortriptyline—Asthenia—Calcitriol—osteoporosis	0.000319	0.00124	CcSEcCtD
Nortriptyline—Thrombocytopenia—Zoledronate—osteoporosis	0.000318	0.00123	CcSEcCtD
Nortriptyline—Tachycardia—Zoledronate—osteoporosis	0.000317	0.00123	CcSEcCtD
Nortriptyline—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000316	0.00123	CcSEcCtD
Nortriptyline—Somnolence—Pamidronate—osteoporosis	0.000316	0.00123	CcSEcCtD
Nortriptyline—Pruritus—Calcitriol—osteoporosis	0.000314	0.00122	CcSEcCtD
Nortriptyline—Hyperhidrosis—Zoledronate—osteoporosis	0.000314	0.00122	CcSEcCtD
Nortriptyline—Diarrhoea—Raloxifene—osteoporosis	0.000314	0.00122	CcSEcCtD
Nortriptyline—Dyspepsia—Pamidronate—osteoporosis	0.000313	0.00121	CcSEcCtD
Nortriptyline—Dizziness—Estropipate—osteoporosis	0.000313	0.00121	CcSEcCtD
Nortriptyline—Oedema—Conjugated Estrogens—osteoporosis	0.000313	0.00121	CcSEcCtD
Nortriptyline—Alopecia—Estradiol—osteoporosis	0.000311	0.00121	CcSEcCtD
Nortriptyline—Diarrhoea—Ibandronate—osteoporosis	0.000311	0.0012	CcSEcCtD
Nortriptyline—Anorexia—Zoledronate—osteoporosis	0.00031	0.0012	CcSEcCtD
Nortriptyline—Decreased appetite—Pamidronate—osteoporosis	0.000309	0.0012	CcSEcCtD
Nortriptyline—Dizziness—Alendronate—osteoporosis	0.000308	0.0012	CcSEcCtD
Nortriptyline—Shock—Conjugated Estrogens—osteoporosis	0.000308	0.00119	CcSEcCtD
Nortriptyline—Fatigue—Pamidronate—osteoporosis	0.000307	0.00119	CcSEcCtD
Nortriptyline—Tachycardia—Conjugated Estrogens—osteoporosis	0.000305	0.00118	CcSEcCtD
Nortriptyline—Urticaria—Ethinyl Estradiol—osteoporosis	0.000305	0.00118	CcSEcCtD
Nortriptyline—Constipation—Pamidronate—osteoporosis	0.000304	0.00118	CcSEcCtD
Nortriptyline—Diarrhoea—Calcitriol—osteoporosis	0.000304	0.00118	CcSEcCtD
Nortriptyline—Hypotension—Zoledronate—osteoporosis	0.000304	0.00118	CcSEcCtD
Nortriptyline—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000303	0.00118	CcSEcCtD
Nortriptyline—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000303	0.00118	CcSEcCtD
Nortriptyline—Dizziness—Raloxifene—osteoporosis	0.000303	0.00118	CcSEcCtD
Nortriptyline—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000302	0.00117	CcSEcCtD
Nortriptyline—Tension—Estradiol—osteoporosis	0.000301	0.00117	CcSEcCtD
Nortriptyline—Vomiting—Estropipate—osteoporosis	0.000301	0.00117	CcSEcCtD
Nortriptyline—Dysgeusia—Estradiol—osteoporosis	0.0003	0.00116	CcSEcCtD
Nortriptyline—Dizziness—Ibandronate—osteoporosis	0.0003	0.00116	CcSEcCtD
Nortriptyline—Rash—Estropipate—osteoporosis	0.000299	0.00116	CcSEcCtD
Nortriptyline—Dermatitis—Estropipate—osteoporosis	0.000298	0.00116	CcSEcCtD
Nortriptyline—Anorexia—Conjugated Estrogens—osteoporosis	0.000298	0.00116	CcSEcCtD
Nortriptyline—Nervousness—Estradiol—osteoporosis	0.000298	0.00116	CcSEcCtD
Nortriptyline—Urticaria—Risedronate—osteoporosis	0.000297	0.00115	CcSEcCtD
Nortriptyline—Headache—Estropipate—osteoporosis	0.000297	0.00115	CcSEcCtD
Nortriptyline—Vomiting—Alendronate—osteoporosis	0.000297	0.00115	CcSEcCtD
Nortriptyline—Abdominal pain—Risedronate—osteoporosis	0.000296	0.00115	CcSEcCtD
Nortriptyline—Body temperature increased—Risedronate—osteoporosis	0.000296	0.00115	CcSEcCtD
Nortriptyline—Rash—Alendronate—osteoporosis	0.000294	0.00114	CcSEcCtD
Nortriptyline—Insomnia—Zoledronate—osteoporosis	0.000294	0.00114	CcSEcCtD
Nortriptyline—Dermatitis—Alendronate—osteoporosis	0.000294	0.00114	CcSEcCtD
Nortriptyline—Feeling abnormal—Pamidronate—osteoporosis	0.000293	0.00114	CcSEcCtD
Nortriptyline—Hypotension—Conjugated Estrogens—osteoporosis	0.000292	0.00113	CcSEcCtD
Nortriptyline—Headache—Alendronate—osteoporosis	0.000292	0.00113	CcSEcCtD
Nortriptyline—Paraesthesia—Zoledronate—osteoporosis	0.000292	0.00113	CcSEcCtD
Nortriptyline—Vomiting—Raloxifene—osteoporosis	0.000292	0.00113	CcSEcCtD
Nortriptyline—Rash—Raloxifene—osteoporosis	0.000289	0.00112	CcSEcCtD
Nortriptyline—Dermatitis—Raloxifene—osteoporosis	0.000289	0.00112	CcSEcCtD
Nortriptyline—Somnolence—Zoledronate—osteoporosis	0.000289	0.00112	CcSEcCtD
Nortriptyline—Vomiting—Ibandronate—osteoporosis	0.000289	0.00112	CcSEcCtD
Nortriptyline—Tremor—Estradiol—osteoporosis	0.000287	0.00111	CcSEcCtD
Nortriptyline—Headache—Raloxifene—osteoporosis	0.000287	0.00111	CcSEcCtD
Nortriptyline—Rash—Ibandronate—osteoporosis	0.000286	0.00111	CcSEcCtD
Nortriptyline—Dermatitis—Ibandronate—osteoporosis	0.000286	0.00111	CcSEcCtD
Nortriptyline—Dyspepsia—Zoledronate—osteoporosis	0.000286	0.00111	CcSEcCtD
Nortriptyline—Ill-defined disorder—Estradiol—osteoporosis	0.000285	0.0011	CcSEcCtD
Nortriptyline—Headache—Ibandronate—osteoporosis	0.000284	0.0011	CcSEcCtD
Nortriptyline—Insomnia—Conjugated Estrogens—osteoporosis	0.000283	0.0011	CcSEcCtD
Nortriptyline—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000283	0.0011	CcSEcCtD
Nortriptyline—Vomiting—Calcitriol—osteoporosis	0.000283	0.0011	CcSEcCtD
Nortriptyline—Decreased appetite—Zoledronate—osteoporosis	0.000282	0.0011	CcSEcCtD
Nortriptyline—Agitation—Estradiol—osteoporosis	0.000282	0.00109	CcSEcCtD
Nortriptyline—Nausea—Estropipate—osteoporosis	0.000281	0.00109	CcSEcCtD
Nortriptyline—Abdominal pain—Pamidronate—osteoporosis	0.000281	0.00109	CcSEcCtD
Nortriptyline—Body temperature increased—Pamidronate—osteoporosis	0.000281	0.00109	CcSEcCtD
Nortriptyline—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000281	0.00109	CcSEcCtD
Nortriptyline—Rash—Calcitriol—osteoporosis	0.00028	0.00109	CcSEcCtD
Nortriptyline—Fatigue—Zoledronate—osteoporosis	0.00028	0.00109	CcSEcCtD
Nortriptyline—Dermatitis—Calcitriol—osteoporosis	0.00028	0.00109	CcSEcCtD
Nortriptyline—Headache—Calcitriol—osteoporosis	0.000278	0.00108	CcSEcCtD
Nortriptyline—Somnolence—Conjugated Estrogens—osteoporosis	0.000278	0.00108	CcSEcCtD
Nortriptyline—Constipation—Zoledronate—osteoporosis	0.000278	0.00108	CcSEcCtD
Nortriptyline—Nausea—Alendronate—osteoporosis	0.000277	0.00107	CcSEcCtD
Nortriptyline—Malaise—Estradiol—osteoporosis	0.000277	0.00107	CcSEcCtD
Nortriptyline—Hypersensitivity—Risedronate—osteoporosis	0.000276	0.00107	CcSEcCtD
Nortriptyline—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000275	0.00107	CcSEcCtD
Nortriptyline—Asthenia—Ethinyl Estradiol—osteoporosis	0.000275	0.00107	CcSEcCtD
Nortriptyline—Syncope—Estradiol—osteoporosis	0.000275	0.00107	CcSEcCtD
Nortriptyline—Nausea—Raloxifene—osteoporosis	0.000272	0.00106	CcSEcCtD
Nortriptyline—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000272	0.00105	CcSEcCtD
Nortriptyline—Pruritus—Ethinyl Estradiol—osteoporosis	0.000272	0.00105	CcSEcCtD
Nortriptyline—Palpitations—Estradiol—osteoporosis	0.000271	0.00105	CcSEcCtD
Nortriptyline—Fatigue—Conjugated Estrogens—osteoporosis	0.00027	0.00105	CcSEcCtD
Nortriptyline—Nausea—Ibandronate—osteoporosis	0.00027	0.00105	CcSEcCtD
Nortriptyline—Loss of consciousness—Estradiol—osteoporosis	0.00027	0.00105	CcSEcCtD
Nortriptyline—Asthenia—Risedronate—osteoporosis	0.000268	0.00104	CcSEcCtD
Nortriptyline—Feeling abnormal—Zoledronate—osteoporosis	0.000268	0.00104	CcSEcCtD
Nortriptyline—Constipation—Conjugated Estrogens—osteoporosis	0.000268	0.00104	CcSEcCtD
Nortriptyline—Hypertension—Estradiol—osteoporosis	0.000265	0.00103	CcSEcCtD
Nortriptyline—Pruritus—Risedronate—osteoporosis	0.000265	0.00103	CcSEcCtD
Nortriptyline—Nausea—Calcitriol—osteoporosis	0.000264	0.00102	CcSEcCtD
Nortriptyline—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000263	0.00102	CcSEcCtD
Nortriptyline—Hypersensitivity—Pamidronate—osteoporosis	0.000262	0.00102	CcSEcCtD
Nortriptyline—Anxiety—Estradiol—osteoporosis	0.00026	0.00101	CcSEcCtD
Nortriptyline—Urticaria—Zoledronate—osteoporosis	0.000258	0.001	CcSEcCtD
Nortriptyline—Discomfort—Estradiol—osteoporosis	0.000258	0.001	CcSEcCtD
Nortriptyline—Abdominal pain—Zoledronate—osteoporosis	0.000257	0.000996	CcSEcCtD
Nortriptyline—Body temperature increased—Zoledronate—osteoporosis	0.000257	0.000996	CcSEcCtD
Nortriptyline—Diarrhoea—Risedronate—osteoporosis	0.000256	0.000993	CcSEcCtD
Nortriptyline—Dry mouth—Estradiol—osteoporosis	0.000255	0.00099	CcSEcCtD
Nortriptyline—Asthenia—Pamidronate—osteoporosis	0.000255	0.000989	CcSEcCtD
Nortriptyline—Dizziness—Ethinyl Estradiol—osteoporosis	0.000254	0.000984	CcSEcCtD
Nortriptyline—Confusional state—Estradiol—osteoporosis	0.000252	0.000979	CcSEcCtD
Nortriptyline—Pruritus—Pamidronate—osteoporosis	0.000252	0.000976	CcSEcCtD
Nortriptyline—Oedema—Estradiol—osteoporosis	0.00025	0.000971	CcSEcCtD
Nortriptyline—Urticaria—Conjugated Estrogens—osteoporosis	0.000249	0.000964	CcSEcCtD
Nortriptyline—Dizziness—Risedronate—osteoporosis	0.000247	0.000959	CcSEcCtD
Nortriptyline—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000247	0.000959	CcSEcCtD
Nortriptyline—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000247	0.000959	CcSEcCtD
Nortriptyline—Shock—Estradiol—osteoporosis	0.000246	0.000955	CcSEcCtD
Nortriptyline—Tachycardia—Estradiol—osteoporosis	0.000244	0.000947	CcSEcCtD
Nortriptyline—Vomiting—Ethinyl Estradiol—osteoporosis	0.000244	0.000946	CcSEcCtD
Nortriptyline—Diarrhoea—Pamidronate—osteoporosis	0.000243	0.000944	CcSEcCtD
Nortriptyline—Hyperhidrosis—Estradiol—osteoporosis	0.000242	0.000938	CcSEcCtD
Nortriptyline—Rash—Ethinyl Estradiol—osteoporosis	0.000242	0.000938	CcSEcCtD
Nortriptyline—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000242	0.000937	CcSEcCtD
Nortriptyline—Headache—Ethinyl Estradiol—osteoporosis	0.00024	0.000932	CcSEcCtD
Nortriptyline—Hypersensitivity—Zoledronate—osteoporosis	0.000239	0.000928	CcSEcCtD
Nortriptyline—Vomiting—Risedronate—osteoporosis	0.000238	0.000922	CcSEcCtD
Nortriptyline—Rash—Risedronate—osteoporosis	0.000236	0.000915	CcSEcCtD
Nortriptyline—Dermatitis—Risedronate—osteoporosis	0.000236	0.000914	CcSEcCtD
Nortriptyline—Dizziness—Pamidronate—osteoporosis	0.000235	0.000912	CcSEcCtD
Nortriptyline—Headache—Risedronate—osteoporosis	0.000234	0.000909	CcSEcCtD
Nortriptyline—Asthenia—Zoledronate—osteoporosis	0.000233	0.000904	CcSEcCtD
Nortriptyline—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00023	0.000894	CcSEcCtD
Nortriptyline—Pruritus—Zoledronate—osteoporosis	0.00023	0.000891	CcSEcCtD
Nortriptyline—Nausea—Ethinyl Estradiol—osteoporosis	0.000228	0.000884	CcSEcCtD
Nortriptyline—Insomnia—Estradiol—osteoporosis	0.000226	0.000878	CcSEcCtD
Nortriptyline—Vomiting—Pamidronate—osteoporosis	0.000226	0.000877	CcSEcCtD
Nortriptyline—Paraesthesia—Estradiol—osteoporosis	0.000225	0.000872	CcSEcCtD
Nortriptyline—Asthenia—Conjugated Estrogens—osteoporosis	0.000224	0.00087	CcSEcCtD
Nortriptyline—Rash—Pamidronate—osteoporosis	0.000224	0.00087	CcSEcCtD
Nortriptyline—Dermatitis—Pamidronate—osteoporosis	0.000224	0.000869	CcSEcCtD
Nortriptyline—Headache—Pamidronate—osteoporosis	0.000223	0.000864	CcSEcCtD
Nortriptyline—Somnolence—Estradiol—osteoporosis	0.000223	0.000863	CcSEcCtD
Nortriptyline—Diarrhoea—Zoledronate—osteoporosis	0.000222	0.000862	CcSEcCtD
Nortriptyline—Nausea—Risedronate—osteoporosis	0.000222	0.000862	CcSEcCtD
Nortriptyline—Pruritus—Conjugated Estrogens—osteoporosis	0.000221	0.000858	CcSEcCtD
Nortriptyline—Dyspepsia—Estradiol—osteoporosis	0.00022	0.000855	CcSEcCtD
Nortriptyline—Decreased appetite—Estradiol—osteoporosis	0.000218	0.000844	CcSEcCtD
Nortriptyline—Fatigue—Estradiol—osteoporosis	0.000216	0.000837	CcSEcCtD
Nortriptyline—Dizziness—Zoledronate—osteoporosis	0.000215	0.000833	CcSEcCtD
Nortriptyline—Constipation—Estradiol—osteoporosis	0.000214	0.00083	CcSEcCtD
Nortriptyline—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000214	0.00083	CcSEcCtD
Nortriptyline—Nausea—Pamidronate—osteoporosis	0.000211	0.000819	CcSEcCtD
Nortriptyline—Dizziness—Conjugated Estrogens—osteoporosis	0.000207	0.000802	CcSEcCtD
Nortriptyline—Vomiting—Zoledronate—osteoporosis	0.000207	0.000801	CcSEcCtD
Nortriptyline—Feeling abnormal—Estradiol—osteoporosis	0.000206	0.0008	CcSEcCtD
Nortriptyline—Rash—Zoledronate—osteoporosis	0.000205	0.000794	CcSEcCtD
Nortriptyline—Dermatitis—Zoledronate—osteoporosis	0.000205	0.000794	CcSEcCtD
Nortriptyline—Headache—Zoledronate—osteoporosis	0.000204	0.000789	CcSEcCtD
Nortriptyline—Vomiting—Conjugated Estrogens—osteoporosis	0.000199	0.000771	CcSEcCtD
Nortriptyline—Urticaria—Estradiol—osteoporosis	0.000199	0.000771	CcSEcCtD
Nortriptyline—Body temperature increased—Estradiol—osteoporosis	0.000198	0.000767	CcSEcCtD
Nortriptyline—Abdominal pain—Estradiol—osteoporosis	0.000198	0.000767	CcSEcCtD
Nortriptyline—Rash—Conjugated Estrogens—osteoporosis	0.000197	0.000765	CcSEcCtD
Nortriptyline—Dermatitis—Conjugated Estrogens—osteoporosis	0.000197	0.000764	CcSEcCtD
Nortriptyline—Headache—Conjugated Estrogens—osteoporosis	0.000196	0.00076	CcSEcCtD
Nortriptyline—Nausea—Zoledronate—osteoporosis	0.000193	0.000748	CcSEcCtD
Nortriptyline—Nausea—Conjugated Estrogens—osteoporosis	0.000186	0.00072	CcSEcCtD
Nortriptyline—Hypersensitivity—Estradiol—osteoporosis	0.000184	0.000715	CcSEcCtD
Nortriptyline—Asthenia—Estradiol—osteoporosis	0.00018	0.000697	CcSEcCtD
Nortriptyline—Pruritus—Estradiol—osteoporosis	0.000177	0.000687	CcSEcCtD
Nortriptyline—Diarrhoea—Estradiol—osteoporosis	0.000171	0.000664	CcSEcCtD
Nortriptyline—Dizziness—Estradiol—osteoporosis	0.000166	0.000642	CcSEcCtD
Nortriptyline—Vomiting—Estradiol—osteoporosis	0.000159	0.000617	CcSEcCtD
Nortriptyline—Rash—Estradiol—osteoporosis	0.000158	0.000612	CcSEcCtD
Nortriptyline—Dermatitis—Estradiol—osteoporosis	0.000158	0.000612	CcSEcCtD
Nortriptyline—Headache—Estradiol—osteoporosis	0.000157	0.000608	CcSEcCtD
Nortriptyline—Nausea—Estradiol—osteoporosis	0.000149	0.000577	CcSEcCtD
Nortriptyline—PTGS1—Metabolism—MTHFR—osteoporosis	1.36e-05	0.000138	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.35e-05	0.000138	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—POMC—osteoporosis	1.35e-05	0.000138	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.35e-05	0.000137	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—POMC—osteoporosis	1.35e-05	0.000137	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.34e-05	0.000137	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6R—osteoporosis	1.34e-05	0.000136	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—LEP—osteoporosis	1.34e-05	0.000136	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6R—osteoporosis	1.33e-05	0.000136	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—ESR1—osteoporosis	1.33e-05	0.000136	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6R—osteoporosis	1.33e-05	0.000136	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IRS1—osteoporosis	1.32e-05	0.000134	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6R—osteoporosis	1.32e-05	0.000134	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—P4HB—osteoporosis	1.31e-05	0.000134	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	1.31e-05	0.000134	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—ADCY5—osteoporosis	1.31e-05	0.000133	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—GPX1—osteoporosis	1.3e-05	0.000133	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ENO1—osteoporosis	1.3e-05	0.000133	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GAPDH—osteoporosis	1.29e-05	0.000131	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PSMA5—osteoporosis	1.28e-05	0.000131	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PSMA2—osteoporosis	1.28e-05	0.000131	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IRS2—osteoporosis	1.28e-05	0.000131	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.28e-05	0.000131	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.28e-05	0.00013	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—ESR1—osteoporosis	1.28e-05	0.00013	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.27e-05	0.00013	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—POMC—osteoporosis	1.27e-05	0.000129	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—IDH2—osteoporosis	1.27e-05	0.000129	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—RAP1A—osteoporosis	1.26e-05	0.000128	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—LEP—osteoporosis	1.26e-05	0.000128	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IRS1—osteoporosis	1.24e-05	0.000127	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6R—osteoporosis	1.24e-05	0.000126	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.24e-05	0.000126	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.23e-05	0.000125	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IGF1—osteoporosis	1.22e-05	0.000125	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	1.22e-05	0.000124	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—MTHFR—osteoporosis	1.2e-05	0.000123	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—ESR1—osteoporosis	1.2e-05	0.000122	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ENO1—osteoporosis	1.2e-05	0.000122	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—POMC—osteoporosis	1.2e-05	0.000122	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.19e-05	0.000122	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IRS1—osteoporosis	1.19e-05	0.000121	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ENO1—osteoporosis	1.19e-05	0.000121	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PSMA2—osteoporosis	1.18e-05	0.00012	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PSMA5—osteoporosis	1.18e-05	0.00012	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SPP1—osteoporosis	1.18e-05	0.00012	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PSMA2—osteoporosis	1.17e-05	0.000119	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PSMA5—osteoporosis	1.17e-05	0.000119	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6R—osteoporosis	1.17e-05	0.000119	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CYP19A1—osteoporosis	1.16e-05	0.000118	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ACP5—osteoporosis	1.16e-05	0.000118	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IGF1—osteoporosis	1.15e-05	0.000117	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—POMC—osteoporosis	1.15e-05	0.000117	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.12e-05	0.000114	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IRS1—osteoporosis	1.12e-05	0.000114	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6R—osteoporosis	1.12e-05	0.000114	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.12e-05	0.000114	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.11e-05	0.000113	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.1e-05	0.000113	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IGF1—osteoporosis	1.1e-05	0.000112	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—ADCY5—osteoporosis	1.1e-05	0.000112	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—ADCY5—osteoporosis	1.1e-05	0.000112	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—ADCY5—osteoporosis	1.1e-05	0.000112	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—GPX1—osteoporosis	1.1e-05	0.000112	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—ADCY5—osteoporosis	1.1e-05	0.000112	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—GPX1—osteoporosis	1.1e-05	0.000112	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.1e-05	0.000112	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—ADCY5—osteoporosis	1.09e-05	0.000112	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—LEP—osteoporosis	1.09e-05	0.000112	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—LEP—osteoporosis	1.09e-05	0.000111	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—POMC—osteoporosis	1.09e-05	0.000111	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SPP1—osteoporosis	1.09e-05	0.000111	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—ADCY5—osteoporosis	1.08e-05	0.00011	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.08e-05	0.00011	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—POMC—osteoporosis	1.08e-05	0.00011	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—TPI1—osteoporosis	1.08e-05	0.00011	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.07e-05	0.000109	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SPP1—osteoporosis	1.07e-05	0.000109	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IRS2—osteoporosis	1.07e-05	0.000109	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SPP1—osteoporosis	1.06e-05	0.000108	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SPP1—osteoporosis	1.06e-05	0.000108	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6R—osteoporosis	1.05e-05	0.000107	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SPP1—osteoporosis	1.05e-05	0.000107	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.05e-05	0.000107	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.04e-05	0.000106	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—LEP—osteoporosis	1.04e-05	0.000106	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.04e-05	0.000106	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.04e-05	0.000106	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IGF1—osteoporosis	1.04e-05	0.000106	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ENO1—osteoporosis	1.02e-05	0.000103	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—MTHFR—osteoporosis	1.01e-05	0.000103	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—P4HB—osteoporosis	1.01e-05	0.000103	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—MTHFR—osteoporosis	1.01e-05	0.000103	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PSMA2—osteoporosis	1e-05	0.000102	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PSMA5—osteoporosis	1e-05	0.000102	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GAPDH—osteoporosis	9.95e-06	0.000101	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—ESR1—osteoporosis	9.95e-06	0.000101	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TGFB1—osteoporosis	9.92e-06	0.000101	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IRS2—osteoporosis	9.82e-06	0.0001	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IRS1—osteoporosis	9.76e-06	9.95e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IRS1—osteoporosis	9.71e-06	9.9e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—RAP1A—osteoporosis	9.69e-06	9.88e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IRS2—osteoporosis	9.66e-06	9.85e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IRS2—osteoporosis	9.64e-06	9.83e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—POMC—osteoporosis	9.63e-06	9.82e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IRS2—osteoporosis	9.61e-06	9.79e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—LEP—osteoporosis	9.61e-06	9.79e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CYP19A1—osteoporosis	9.58e-06	9.77e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IRS2—osteoporosis	9.58e-06	9.76e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CYP19A1—osteoporosis	9.5e-06	9.68e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IRS2—osteoporosis	9.49e-06	9.67e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—ADCY5—osteoporosis	9.48e-06	9.66e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IRS2—osteoporosis	9.46e-06	9.64e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—LEP—osteoporosis	9.46e-06	9.64e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GPX1—osteoporosis	9.45e-06	9.63e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—LEP—osteoporosis	9.44e-06	9.61e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—LEP—osteoporosis	9.4e-06	9.58e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—POMC—osteoporosis	9.4e-06	9.58e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—LEP—osteoporosis	9.37e-06	9.55e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—POMC—osteoporosis	9.35e-06	9.53e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—IL6—osteoporosis	9.34e-06	9.52e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IRS1—osteoporosis	9.3e-06	9.48e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—LEP—osteoporosis	9.28e-06	9.46e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—LEP—osteoporosis	9.26e-06	9.43e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—ESR1—osteoporosis	9.17e-06	9.35e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6R—osteoporosis	9.17e-06	9.35e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6R—osteoporosis	9.12e-06	9.3e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IGF1—osteoporosis	9.04e-06	9.22e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—ESR1—osteoporosis	9.03e-06	9.2e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—ESR1—osteoporosis	9.01e-06	9.18e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IGF1—osteoporosis	9e-06	9.17e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—ESR1—osteoporosis	8.98e-06	9.15e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—POMC—osteoporosis	8.95e-06	9.12e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—ESR1—osteoporosis	8.95e-06	9.12e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—ESR1—osteoporosis	8.86e-06	9.03e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—ESR1—osteoporosis	8.84e-06	9.01e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—IL6—osteoporosis	8.81e-06	8.98e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6R—osteoporosis	8.73e-06	8.9e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—MTHFR—osteoporosis	8.72e-06	8.89e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IGF1—osteoporosis	8.61e-06	8.78e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IRS1—osteoporosis	8.57e-06	8.74e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ADCY5—osteoporosis	8.51e-06	8.67e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GPX1—osteoporosis	8.48e-06	8.65e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—IL6—osteoporosis	8.44e-06	8.6e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IRS1—osteoporosis	8.44e-06	8.6e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IRS1—osteoporosis	8.42e-06	8.58e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IRS1—osteoporosis	8.39e-06	8.55e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IRS1—osteoporosis	8.36e-06	8.52e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IRS1—osteoporosis	8.28e-06	8.44e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IRS1—osteoporosis	8.26e-06	8.42e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—POMC—osteoporosis	8.26e-06	8.41e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—POMC—osteoporosis	8.12e-06	8.28e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CYP19A1—osteoporosis	8.12e-06	8.27e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—POMC—osteoporosis	8.12e-06	8.27e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—POMC—osteoporosis	8.11e-06	8.26e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—POMC—osteoporosis	8.1e-06	8.25e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—POMC—osteoporosis	8.08e-06	8.23e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—POMC—osteoporosis	8.05e-06	8.21e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6R—osteoporosis	8.05e-06	8.21e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—POMC—osteoporosis	7.98e-06	8.13e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—POMC—osteoporosis	7.95e-06	8.11e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IGF1—osteoporosis	7.94e-06	8.09e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—IL6—osteoporosis	7.94e-06	8.09e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6R—osteoporosis	7.92e-06	8.07e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6R—osteoporosis	7.91e-06	8.06e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6R—osteoporosis	7.88e-06	8.03e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6R—osteoporosis	7.86e-06	8.01e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ENO1—osteoporosis	7.84e-06	7.99e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ADCY5—osteoporosis	7.83e-06	7.98e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—MTHFR—osteoporosis	7.83e-06	7.98e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IGF1—osteoporosis	7.81e-06	7.96e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GPX1—osteoporosis	7.8e-06	7.95e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IGF1—osteoporosis	7.8e-06	7.95e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6R—osteoporosis	7.78e-06	7.93e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IGF1—osteoporosis	7.77e-06	7.92e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ADCY5—osteoporosis	7.76e-06	7.91e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6R—osteoporosis	7.76e-06	7.91e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IGF1—osteoporosis	7.75e-06	7.89e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GPX1—osteoporosis	7.74e-06	7.88e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PSMA5—osteoporosis	7.72e-06	7.87e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PSMA2—osteoporosis	7.72e-06	7.87e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IGF1—osteoporosis	7.67e-06	7.82e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IGF1—osteoporosis	7.65e-06	7.8e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MYC—osteoporosis	7.34e-06	7.48e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TGFB1—osteoporosis	7.32e-06	7.46e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MTHFR—osteoporosis	7.2e-06	7.34e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MTHFR—osteoporosis	7.14e-06	7.27e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—POMC—osteoporosis	6.97e-06	7.11e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MYC—osteoporosis	6.93e-06	7.06e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL6—osteoporosis	6.92e-06	7.05e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TGFB1—osteoporosis	6.91e-06	7.04e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL6—osteoporosis	6.88e-06	7.01e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MYC—osteoporosis	6.63e-06	6.76e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ADCY5—osteoporosis	6.63e-06	6.76e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TGFB1—osteoporosis	6.62e-06	6.74e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GPX1—osteoporosis	6.61e-06	6.74e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—osteoporosis	6.59e-06	6.71e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.27e-06	6.38e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—POMC—osteoporosis	6.26e-06	6.38e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MYC—osteoporosis	6.24e-06	6.36e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	6.22e-06	6.34e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MTHFR—osteoporosis	6.1e-06	6.22e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—osteoporosis	6.07e-06	6.19e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—osteoporosis	5.97e-06	6.09e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—osteoporosis	5.96e-06	6.08e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—osteoporosis	5.94e-06	6.06e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—osteoporosis	5.92e-06	6.04e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—osteoporosis	5.87e-06	5.98e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—osteoporosis	5.85e-06	5.96e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—POMC—osteoporosis	5.76e-06	5.87e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—POMC—osteoporosis	5.71e-06	5.82e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—osteoporosis	5.52e-06	5.62e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MYC—osteoporosis	5.44e-06	5.54e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TGFB1—osteoporosis	5.42e-06	5.53e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MYC—osteoporosis	5.41e-06	5.51e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TGFB1—osteoporosis	5.39e-06	5.5e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—osteoporosis	5.21e-06	5.31e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MYC—osteoporosis	5.18e-06	5.27e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	5.16e-06	5.26e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ADCY5—osteoporosis	5.12e-06	5.22e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GPX1—osteoporosis	5.1e-06	5.2e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—osteoporosis	4.99e-06	5.08e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—POMC—osteoporosis	4.88e-06	4.97e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MYC—osteoporosis	4.77e-06	4.86e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TGFB1—osteoporosis	4.76e-06	4.85e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MTHFR—osteoporosis	4.71e-06	4.8e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MYC—osteoporosis	4.7e-06	4.78e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—osteoporosis	4.69e-06	4.78e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MYC—osteoporosis	4.69e-06	4.77e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TGFB1—osteoporosis	4.68e-06	4.77e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TGFB1—osteoporosis	4.67e-06	4.76e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MYC—osteoporosis	4.67e-06	4.76e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TGFB1—osteoporosis	4.66e-06	4.75e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MYC—osteoporosis	4.66e-06	4.74e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TGFB1—osteoporosis	4.64e-06	4.73e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MYC—osteoporosis	4.61e-06	4.7e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TGFB1—osteoporosis	4.6e-06	4.69e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MYC—osteoporosis	4.6e-06	4.69e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	4.59e-06	4.67e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—osteoporosis	4.09e-06	4.16e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—osteoporosis	4.06e-06	4.14e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—osteoporosis	3.89e-06	3.97e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—POMC—osteoporosis	3.77e-06	3.84e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—osteoporosis	3.59e-06	3.66e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—osteoporosis	3.53e-06	3.6e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—osteoporosis	3.52e-06	3.59e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—osteoporosis	3.51e-06	3.58e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—osteoporosis	3.5e-06	3.57e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—osteoporosis	3.47e-06	3.53e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—osteoporosis	3.46e-06	3.52e-05	CbGpPWpGaD
